Gradient Biomodeling LLC
Gradient quantum similarity approach integrates fundamental knowledge from physics, chemistry and biology and translates it into meaningful drug leads.
- Stage Product In Development
- Industry Biotechnology
- Location Park City, UT, USA
- Currency USD
- Employees 2
- Website gradientbiomodeling.com
Company Summary
Biomolecular interactions are quantum in nature. Gradient has developed and validated a computational platform for their theoretical modeling. The methodology is based on quantum representation of chemical structures and machine-learning fuzzy-decision algorithms, and takes advantage of the latest bioassay and biomedical big data developments. The technology has been successfully applied against a wide range of therapeutic targets.
Team
-
Martin N MartinovChief Technology Officer
Dr. Martinov has implemented extensive IT solutions in pharmaceuticals, diagnostics, and imaging. He holds an MS in Biotechnology from University of Sofia, a PhD in Molecular Biophysics from Florida State, and has done post-doctoral research at Rensselaer Polytechnic Institute.
-
Nick KaludovScientific Operations
Dr. Kaludov is an experienced executive with extensive R&D expertise and a successful industry track record. As an industry executive has transformed two biotechnology research platforms into product pipelines, taken a product through pre-clinical development, founded one biotechnology company, and established several corporate alliances resulting in new IP and increased revenues.
-
Antoan GoshevVice President, IT
Mr. Goshev is an IT professional with extensive experience in development of Computer Graphics and Scientific Calculations software; IT operations and IT outsourcing. He holds B.Sc. in Mathematics and M.Sc. in Computer Science from University of Sofia.
Advisors
-
Medicinal Chemistry Advisor
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.